Retraction
High Uric Acid Inhibits Cardiomyocyte Viability Through the ERK/P38 Pathway via Oxidative Stress
Paper Information
Record ID:
33729
Author(s):
Publication Date:
February 08, 2018
Retraction Date:
July 01, 2021
(4.4 years years ago)
Subjects:
Institutions:
- Department of Internal Medicine, The Second Affiliated Hospital of Shantou, University Medical College, Shantou, China
- Department of Internal Medicine, Chaozhou People's Hospital, Chaozhou, China
- Department of Intensive Care Unit, Peking University Shenzhen Hospital, Shenzhen, China
- Department of Internal Medicine, The First Affiliated Hospital of Shantou University Medical College, Shantou, China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Cellular Physiol Biochem Press
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (52)
52
Total Citations27
Post-Retraction(51.9%)
25
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
9
Within 1 year
9
After 2+ years
1420
Days since retraction (latest)
U-Shaped Relationship Between Functional Outcome and Serum Uric Acid in Ischemic Stroke
Yimin Yang, Ying Zhang, Yanhua Li et al. (7 authors)
Cellular Physiology and Biochemistry
Open Access
Published: Jan 2018
25 citations
25 citations
1277 days before retraction
Zurampic Protects Pancreatic β-Cells from High Uric Acid Induced-Damage by Inhibiting URAT1 and Inactivating the ROS/AMPK/ERK Pathways
Ying Xin, Kun Wang, Zhaotong Jia et al. (10 authors)
Cellular Physiology and Biochemistry
Open Access
Published: Jan 2018
14 citations
14 citations
1277 days before retraction
Quick Stats
Total Citations:
52
Years Since Retraction:
4.4 years
Open Access:
Yes
Last Checked:
Jul 24, 2025